Novus Biologicals Awards Contract to Biovista Inc. to Drive its Web-Based
Novus Explorer Service
CHARLOTTESVILLE, VA,
"We are very pleased that Novus selected our BEA platform to drive this exciting new service," said Aris Persidis, Ph.D., President of Biovista. "The flexibility of our BEA platform has allowed us to put together in a relatively short amount of time this custom solution which meets Novus' criteria for useful information provision coupled with specifics from Novus' own line of products," Dr Persidis added.
"Novus is glad to have selected Biovista's proven technology to support service we hope will be of use to our site visitors and existing customers", said
About Biovista and the BEA platform
Biovista applies high-throughput discovery efforts to finding solutions for commercially relevant unmet medical needs. Biovista's proprietary repositioning technology allows the company's experts to perform mechanism-of-action based analyses and systematically assess clinical outcomes in any therapeutic area of interest, at relatively low cost and very short time spans. The BEA platform is a literature mining solution that allows researchers to search scientific literature in ways that support scientific discovery in a systematic way.
For further information: For further information: Dr. Aris Persidis, President, Biovista, (434) 242-6514, [email protected]
Share this article